logo

Acquisitions And Launches Will Expand Global Technology Reach

AN
Consensus Narrative from 3 Analysts
Published
24 Dec 24
Updated
01 May 25
Share
AnalystConsensusTarget's Fair Value
SEK 494.33
20.9% undervalued intrinsic discount
01 May
SEK 390.80
Loading
1Y
1.0%
7D
7.1%

Author's Valuation

SEK 494.3

20.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Key Takeaways

  • Mycronic's acquisitions and new technology launches are bolstering revenue and market position, particularly in the Global Technologies and display industries.
  • Strategic geographic expansion and increased R&D investments indicate potential for long-term revenue growth and market diversification.
  • The combination of tariffs, demand weakness, and currency fluctuations is leading to declining revenues and earnings instability in Mycronic's High Flex division.

Catalysts

About Mycronic
    Develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Mycronic's recent acquisitions, such as Hprobe and RoBAT, are expected to expand its offerings in the Global Technologies division with unique technologies for testing MRAM and PCBs, potentially leading to increased revenue and strengthened market position.
  • The successful launch of the Prexision 8000 Evo, a high-end machine for mask writing in the display industry, confirms alignment with industry needs, and its reception may drive future order volumes, positively impacting revenue and earnings.
  • Strong growth in the company's High Volume division, particularly in the Chinese domestic market, suggests potential for increased sales and revenue growth, supported by a robust order backlog.
  • Continued expansion into new regions, like Southeast Asia, for High Volume production indicates strategic geographic diversification, which may enhance revenue stability and long-term growth prospects.
  • Increased R&D investments in Pattern Generators, with a focus on new product development and market opportunities such as inspection and quality control, could support long-term revenue growth and competitive positioning.

Mycronic Earnings and Revenue Growth

Mycronic Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Mycronic's revenue will grow by 3.7% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 24.2% today to 22.4% in 3 years time.
  • Analysts expect earnings to reach SEK 1.9 billion (and earnings per share of SEK 19.47) by about May 2028, up from SEK 1.8 billion today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 30.4x on those 2028 earnings, up from 20.8x today. This future PE is greater than the current PE for the GB Electronic industry at 26.0x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 5.86%, as per the Simply Wall St company report.

Mycronic Future Earnings Per Share Growth

Mycronic Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The impact of new tariffs in the U.S. has caused delays in deliveries within the High Flex division, negatively impacting quarterly earnings by SEK 15 million and potentially affecting future revenues due to hesitation in investments.
  • There is noted weakness in demand within the High Flex division, particularly in Europe, leading to a decrease in order intake by 12% and negatively impacting net sales and earnings.
  • The financial outlook is uncertain due to fluctuations in exchange rates and the potential indirect effects of tariffs, which could lead to lower projected sales and impact both revenue and net margins.
  • Uncertainty in the investment climate and potential hesitation to invest due to market conditions and currency fluctuations could lead to volatility in order intake and revenues, especially in divisions with shorter lead times like High Flex.
  • Dependency on a limited number of customers in some divisions, such as Die Bonding in the Global Technologies division, can lead to fluctuating order intake, impacting revenue stability and earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of SEK494.333 for Mycronic based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be SEK8.4 billion, earnings will come to SEK1.9 billion, and it would be trading on a PE ratio of 30.4x, assuming you use a discount rate of 5.9%.
  • Given the current share price of SEK384.6, the analyst price target of SEK494.33 is 22.2% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

Warren A.I. is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by Warren A.I. are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that Warren A.I.'s analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives